SCHEMBL17816178

SCHEMBL17816178

O=C(Nc1cc(F)c(F)c(F)c1)c1ccc(C(F)(F)I)c(SC2CCC(O)CC2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KCNH2 Q12809 1/20 0.35
KCNQ3 O43525 3/20 0.35
KCNQ2 O43526 3/20 0.35
KCNE1 P15382 2/20 0.35
KCNQ1 P51787 2/20 0.35
RARA P10276 2/20 0.33
RARB P10826 2/20 0.33
RARG P13631 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 2/20 0.33
MAOB P27338 2/20 0.33
P2RY14 Q15391 1/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17792180 0.92 KCNQ3 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17816174 0.86 NPC1 (0.46) KCNQ3KCNQ2KCNE1KCNQ1MAPT
SCHEMBL17792077 0.86 LMNA (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL19473175 0.85 KCNQ3 (0.37) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17816084 0.85 CYP1A2 (0.37) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17792174 0.83 KCNQ3 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL19319194 0.83 MAOB (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17792175 0.83 MAOB (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17792176 0.82 NAMPT (0.42) CYP1A2CYP3A4CYP2C19KCNQ3KCNQ2
SCHEMBL17792129 0.82 TAS1R3 (0.48) CYP2C9KCNQ3KCNQ2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed